The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 97, Issue 2, 2004, Pages 190-195

  Gorsky, Meir ^a   Epstein, Joel B ^b,c   Parry, Jamie ^d   Epstein, Matthew S ^e   Le, Nhu D ^d   Silverman Jr , Sol ^f  

^a TEL AVIV UNIVERSITY   (Israel)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

^e VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETHANECHOL; PILOCARPINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOSALIVATION; MALE; MICTURITION DISORDER; MUSCLE CRAMP; NAUSEA; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SWEATING; TACHYCARDIA; TREATMENT OUTCOME; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 1242351500     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2003.08.031     Document Type: Article

References (22)

1. Schuller D.E., Stevens P., Clausen K.P., Olsen J., Gahbauer R., Martin M. Treatment of radiation side effects with oral pilocarpine. J Surg Oncol. 42:1989;272-276.
2. Greenspan D., Daniels T.E. Effectiveness of pilocarpine in postradiation xerostomia. Cancer. 59:1987;1123-1125.
3. Fox P.C., Atkinson J.C., Macynski A.A., et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med. 151:1991;1149-1152.
4. Johnson J.T., Ferretti G.A., Nethery W.J., et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. New Engl J Med. 329:1993;390-395.
5. Sangthawan D., Watthanaarpornchai S., Phungrassami T. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia. J Med Assoc Thailand. 84:2001;195-203.
6. Lajtman Z., Krajina Z., Krpan D., Vincelj J., Borcic V., Popovic-Kovacic J. Pilocarpine in the prevention of postirradiation xerostomia. Acta Med Croat. 54:2000;65-67.
7. Horiot J.C., Lipinski F., Schraub S., et al. Post-radiation severe xerostomia relieved by pilocarpine a prospective French cooperative study . Radiother Oncol. 55:2000;233-239.
8. Niedermeier W., Matthaeus C., Meyer C., Staar S., Muller R.P., Schulze H.J. Radiation-induced hyposalivation and its treatment with oral pilocarpine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 86:1998;541-549.
9. Everett H.C. The use of bethanechol chloride with tricyclic antidepressants. Am J Psychiatry. 132:1975;1202-1204.
10. Silverman S. Jr. Oral cancer. 3rd ed:1990;American Cancer Society, Atlanta.
11. Epstein J.B., Burchell J.L., Emerton S., Le N.D., Silverman S. A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 77:1994;610-614.
12. Epstein J.B., Schubert M.M. Synergistic effect of sialagogues in management of xerostomia after radiation therapy. Oral Surg Oral Med, Oral Pathol Oral Radiol Endod. 64:1987;179-182.
13. Mateos J.J., Setoain X., Ferre J., et al. Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours. Nucl Med Commun. 22:2001;651-656.
14. Lajtman Z., Krajina Z., Krpan D., Vincelj J., Borcic V., Popovic-Kovacic J. Pilocarpine in the prevention of postirradiation xerostomia. Acta Medica Croatica. 54:2000;65-67.
15. Cooper R.A., Cowan R.A., Owens S.E., et al. Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia? . Eur J Nucl Med. 26:1999;220-225.
16. Epstein J.B., Scully C. The role of saliva in oral health and the causes and effects of xerostomia. J Canad Dent Assoc. 58:1992;217-221.
17. Ship J.A., Fox P.C., Baum B.J. How much saliva is enough? 'Normal' function defined. J Am Dent Assoc. 122:1991;63-69.
18. LeVeque F.G., Montgomery M., Potter D., et al. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol. 11:1993;1124-1131.
19. Henson B.S., Inglehart M.R., Eisbruch A., Ship J.A. Prreserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol. 37:2001;84-93.
20. Eisbruch A., Ship J.A., Kim H.M., Ten Haken R.K. Partial irradiation of the parotid gland. Sem Radiat Oncol. 11:2001;234-239.
21. Eisbruch A., Kim H.M., Terrell J.E., Marsh L.H., Dawson L.A., Ship J.A. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 50:2001;695-704.
22. Eisbruch A., Dawson L.A., Kim H.M., et al. Conformal and intensity modulated irradiation of head and neck cancer the potential for improved target irradiation, salivary galnd function, and quality of life . Acta Otorhino-Laryngol Belg. 53:1999;271-275.